Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group-Reference-Cited by-同舟云学术

Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

Published:2008-07 Issue:7pt1 Volume:23 Page:1094-1104
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Furusyo Norihiro,Kajiwara Eiji,Takahashi Kazuhiro,Nomura Hideyuki,Tanabe Yuichi,Masumoto Akihide,Maruyama Toshihiro,Nakamuta Makoto,Enjoji Munechika,Azuma Koichi,Shimono Junya,Sakai Hironori,Shimoda Shinji,Hayashi Jun,

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2008.05319.x/fullpdf

Reference29 articles.

1. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection;Hayashi;Hepatology,1997

2. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia;Hayashi;J. Infect. Dis.,2000

3. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;Niederau;Hepatology,1998

4. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C;Lindsay;Hepatology,2001

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity;Internal Medicine;2019-02-15

2. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection;World Journal of Gastroenterology;2018-05-28

3. NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b;Journal of Gastroenterology;2016-12-02

4. Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis;Antiviral Research;2016-12

5. Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis;Hepatology Research;2016-06-10